PIM1, a novel target in chemotherapy-resistant triple-negative breast cancer

被引：0
|
作者：
Braso-Maristany, Fara
Filosto, Simone
Catchpole, Steven
Marlow, Rebecca
Quist, Jelmar
Domenech, Erika Francesch
Liccardi, Gianmaria
Zakka, Leila
Serra, Violeta
Gris, Albert
Cheang, Maggie
Patel, Nirmesh
Rosell, Anna Perdrix
Gazinska, Patrycja
Noel, Elodie
Watkins, Jonathan
Marra, Pierfrancesco
Grigoriadis, Anita
Tutt, Andrew
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study
    Yam, Clinton
    Patel, Miral
    Hill, Holly A.
    Sun, Ryan
    Bassett Jr, Roland L.
    Kong, Elisabeth
    Damodaran, Senthil
    Koenig, Kimberly B.
    Abouharb, Sausan
    Saleem, Sadia
    Bisen, Ajit K.
    Murthy, Rashmi K.
    Ramirez, David L.
    Rauch, Gaiane M.
    Adrada, Beatriz E.
    Candelaria, Rosalind P.
    Wang, Xiaoping
    Mittendorf, Elizabeth A.
    Thompson, Alastair M.
    White, Jason B.
    Ravenberg, Elizabeth E.
    Clayborn, Alyson R.
    Ding, Qing-Qing
    Booser, Daniel J.
    Oke, Oluchi
    Brewster, Abenaa M.
    Hortobagyi, Gabriel N.
    Ibrahim, Nuhad K.
    Litton, Jennifer K.
    Valero, Vicente
    Arun, Banu K.
    Tripathy, Debu
    Chang, Jeffrey T.
    Chen, Ken
    Korkut, Anil
    Moulder, Stacy L.
    Huo, Lei
    Lim, Bora
    Ueno, Naoto T.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2823 - 2834
  • [22] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Sutapa Mahata
    Pranab K. Sahoo
    Ranita Pal
    Sinjini Sarkar
    Tanuma Mistry
    Sushmita Ghosh
    Vilas D. Nasare
    Medical Oncology, 39
  • [23] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Mahata, Sutapa
    Sahoo, Pranab K.
    Pal, Ranita
    Sarkar, Sinjini
    Mistry, Tanuma
    Ghosh, Sushmita
    Nasare, Vilas D.
    MEDICAL ONCOLOGY, 2022, 39 (05)
  • [24] PIM-1 kinase: a potential biomarker of triple-negative breast cancer
    Chen, Jieying
    Tang, Guangyu
    ONCOTARGETS AND THERAPY, 2019, 12 : 6267 - 6273
  • [25] PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
    Dai Horiuchi
    Roman Camarda
    Alicia Y Zhou
    Christina Yau
    Olga Momcilovic
    Sanjeev Balakrishnan
    Alexandra N Corella
    Henok Eyob
    Kai Kessenbrock
    Devon A Lawson
    Lindsey A Marsh
    Brittany N Anderton
    Julia Rohrberg
    Ratika Kunder
    Alexey V Bazarov
    Paul Yaswen
    Michael T McManus
    Hope S Rugo
    Zena Werb
    Andrei Goga
    Nature Medicine, 2016, 22 : 1321 - 1329
  • [26] ATR inhibition is a promising radiosensitizing strategy for chemotherapy-resistant triple negative breast cancer (TNBC)
    Mutter, Robert W.
    Kahila, Mohamed M.
    Tu, Xinyi
    Zhou, Qin
    Yu, Jia
    Kalari, Krishna R.
    Wang, Liewei
    Boughey, Judy C.
    Goetz, Matthew P.
    Sarkaria, Jann N.
    Lou, Zhenkun
    CANCER RESEARCH, 2018, 78 (13)
  • [27] PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
    Horiuchi, Dai
    Camarda, Roman
    Zhou, Alicia Y.
    Yau, Christina
    Momcilovic, Olga
    Balakrishnan, Sanjeev
    Corella, Alexandra N.
    Eyob, Henok
    Kessenbrock, Kai
    Lawson, Devon A.
    Marsh, Lindsey A.
    Anderton, Brittany N.
    Rohrberg, Julia
    Kunder, Ratika
    Bazarov, Alexey V.
    Yaswen, Paul
    McManus, Michael T.
    Rugo, Hope S.
    Werb, Zena
    Goga, Andrei
    NATURE MEDICINE, 2016, 22 (11) : 1321 - 1329
  • [28] Identifying novel cancer stem cell target for triple-negative breast cancer
    Liu, Yi
    Choi, Dong Soon
    Grandos-Principal, Sergio
    Qian, Wei
    Burey, Lacey
    Wong, Helen
    Rodriguez-Aguayo, Crisitian
    Sood, Anil
    Li, Zheng
    Wong, Stephen
    Weiss, Heidi
    Dave, Bhuvanesh
    Landis, Melissa
    Chang, Jenny C.
    CANCER RESEARCH, 2015, 75
  • [29] GRB7-a novel target in triple-negative breast cancer
    Giricz, Orsi
    Pero, Stephanie C.
    Krag, David N.
    Sparano, Joseph A.
    Kenny, Paraic A.
    CANCER RESEARCH, 2011, 71
  • [30] DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
    Kurani, Hetakshi
    Razavipour, Seyedeh Fatemeh
    Harikumar, Kuzhuvelil B.
    Dunworth, Matthew
    Ewald, Andrew J.
    Nasir, Apsra
    Pearson, Gray
    Van Booven, Derek
    Zhou, Zhiqun
    Azzam, Diana
    Wahlestedt, Claes
    Slingerland, Joyce
    CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1948 - 1965
12345